[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $alpmy $alpmy sees increased community engagement amidst market volatility. Positive mentions and influential creators are driving engagement, but price fluctuations persist due to market conditions. ### About $alpmy A cryptocurrency project. ### Insights [#](/topic/$alpmy/insights) - $alpmy engagements is up XX% from the previous week. ### Engagements: XXX [#](/topic/$alpmy/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$alpmy/time-series/interactions.tsv) **Current Value**: XXX **Daily Average**: XXX **1 Week**: XXXXX +75% **1 Month**: XXXXX -XX% **1-Year High**: XXXXXX on 2025-08-04 **1-Year Low**: X on 2025-09-24 | Social Network | X | | -------------- | - | | Engagements | XXX | ### Mentions: X [#](/topic/$alpmy/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$alpmy/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Month**: X +33% **1-Year High**: XX on 2025-07-31 **1-Year Low**: X on 2025-04-27 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$alpmy/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$alpmy/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $alpmy in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1 Month**: X no change **1-Year High**: XX on 2025-07-26 **1-Year Low**: X on 2025-04-27 ### Sentiment: XX% [#](/topic/$alpmy/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$alpmy/time-series/sentiment.tsv) **Most Supportive Themes** - **Positive News and Mentions:** (60%) Positive mentions of $alpmy in posts, with high engagement from influential creators. **Most Critical Themes** - **Market Volatility:** (40%) Price fluctuations due to market volatility. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | X | X% | XXX | XX% | X | X% | | | | | | | | | | Total | X | X% | XXX | XX% | X | X% | **Top assets mentioned** In the posts about $alpmy in the last XX hours [Dawn Protocol (DAWN)](/topic/dawn-protocol) [Dawn Protocol (DAWN)](/topic/$dawn) [Piper Sandler Companies (PIPR)](/topic/$pipr) [Amgen, Inc. (AMGN)](/topic/$amgn) [AstraZeneca PLC (AZN)](/topic/$azn) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad) **Top topics mentioned** In the posts about $alpmy in the last XX hours [$4503t](/topic/$4503t), [dawn protocol](/topic/dawn-protocol), [coins defi](/topic/coins-defi), [coins nft](/topic/coins-nft), [$dawn](/topic/$dawn), [$pipr](/topic/$pipr), [stocks healthcare](/topic/stocks-healthcare), [$amgn](/topic/$amgn), [$azn](/topic/$azn), [$bbio](/topic/$bbio), [$sgmo](/topic/$sgmo), [$tsha](/topic/$tsha), [$acad](/topic/$acad), [$avxl](/topic/$avxl), [breakthrough](/topic/breakthrough) ### Top Social Posts [#](/topic/$alpmy/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "@ErnieWorthingK9 Perfect time to buy $SGMO at an incredibly cheap price when Sangamo is under the gun and needs cash. It needs an acquirer. Also Astellas is already a partner. Astellas will never have an opportunity this good and this inexpensive. $ALPMY $4503.T" [X Link](https://x.com/Corona_N_Lyme/status/1976311567663939801) [@Corona_N_Lyme](/creator/x/Corona_N_Lyme) 2025-10-09T15:39Z 1770 followers, XXX engagements "BofA reiterated $TSHA Buy-$8 and says that it thinks BTD validates TSHA-102 as addressing a high unmet need in Rett syndrome as potentially the first disease-modifying therapy for patientsFinalized pivotal trial design retains 6-month interim read $ACAD $AVXL BofA said: TSHA announced that FDA had granted Breakthrough Therapy designation to TSHA-102 based on the 12-patient safety and efficacy data generated from REVEAL Part A. We think the designation validates TSHA-102 as addressing a high unmet need in Rett syndrome as potentially the first disease-modifying therapy for patients. BofA" [X Link](https://x.com/Quantumup1/status/1973777916220592511) [@Quantumup1](/creator/x/Quantumup1) 2025-10-02T15:51Z 3842 followers, 6600 engagements "$ALPMY Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025" [X Link](https://x.com/MarcJacksonLA/status/1973316893781139482) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-01T09:19Z 7575 followers, XXX engagements "H.C. Wainwright reiterated $DAWN at a Buy rating and a $XX price target after getting inbound questions on Ojemda's growth trajectory from investors particularly around the slope into year-end 2025 and the outlook for 2026. This is what H.C. Wainwright had to say in its note to investors:" [X Link](https://x.com/Quantumup1/status/1971552193351160120) [@Quantumup1](/creator/x/Quantumup1) 2025-09-26T12:27Z 3843 followers, 2779 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$alpmy sees increased community engagement amidst market volatility. Positive mentions and influential creators are driving engagement, but price fluctuations persist due to market conditions.
A cryptocurrency project.
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Week: XXXXX +75%
1 Month: XXXXX -XX%
1-Year High: XXXXXX on 2025-08-04
1-Year Low: X on 2025-09-24
Social Network | X |
---|---|
Engagements | XXX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1 Month: X +33%
1-Year High: XX on 2025-07-31
1-Year Low: X on 2025-04-27
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $alpmy in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Month: X no change
1-Year High: XX on 2025-07-26
1-Year Low: X on 2025-04-27
Sentiment 24-Hour Time-Series Raw Data
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | X | X% | XXX | XX% | X | X% |
Total | X | X% | XXX | XX% | X | X% |
Top assets mentioned In the posts about $alpmy in the last XX hours
Dawn Protocol (DAWN) Dawn Protocol (DAWN) Piper Sandler Companies (PIPR) Amgen, Inc. (AMGN) AstraZeneca PLC (AZN) BridgeBio Pharma, Inc. Common Stock (BBIO) Acadia Pharmaceuticals Inc. (ACAD)
Top topics mentioned In the posts about $alpmy in the last XX hours
$4503t, dawn protocol, coins defi, coins nft, $dawn, $pipr, stocks healthcare, $amgn, $azn, $bbio, $sgmo, $tsha, $acad, $avxl, breakthrough
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@ErnieWorthingK9 Perfect time to buy $SGMO at an incredibly cheap price when Sangamo is under the gun and needs cash. It needs an acquirer. Also Astellas is already a partner. Astellas will never have an opportunity this good and this inexpensive. $ALPMY $4503.T"
X Link @Corona_N_Lyme 2025-10-09T15:39Z 1770 followers, XXX engagements
"BofA reiterated $TSHA Buy-$8 and says that it thinks BTD validates TSHA-102 as addressing a high unmet need in Rett syndrome as potentially the first disease-modifying therapy for patientsFinalized pivotal trial design retains 6-month interim read $ACAD $AVXL BofA said: TSHA announced that FDA had granted Breakthrough Therapy designation to TSHA-102 based on the 12-patient safety and efficacy data generated from REVEAL Part A. We think the designation validates TSHA-102 as addressing a high unmet need in Rett syndrome as potentially the first disease-modifying therapy for patients. BofA"
X Link @Quantumup1 2025-10-02T15:51Z 3842 followers, 6600 engagements
"$ALPMY Astellas To Present Pioneering Advances Across Its Portfolio and Pipeline at ESMO 2025"
X Link @MarcJacksonLA 2025-10-01T09:19Z 7575 followers, XXX engagements
"H.C. Wainwright reiterated $DAWN at a Buy rating and a $XX price target after getting inbound questions on Ojemda's growth trajectory from investors particularly around the slope into year-end 2025 and the outlook for 2026. This is what H.C. Wainwright had to say in its note to investors:"
X Link @Quantumup1 2025-09-26T12:27Z 3843 followers, 2779 engagements
/topic/$alpmy